Low-molecular-weight zinc-binding proteins in liver cytosol of the allylisopropylacetamide (AIA) treated rats.
Rats maintained on a normal diet supplemented with 10 microCi 65Zn/day for a period of 10 days were given allylisopropylacetamide (AIA), 400 mg/kg body weight: 24 h later they were killed. Cytosol was prepared from liver cells and analysed by gel filtration on a Sephadex G-75 column. The AIA treatment caused an alteration in the chromatographic pattern of Zn-binding proteins, and a low-molecular-weight fraction appeared.
D000081:Acetamides / Q000494:pharmacology*; D000502:Allylisopropylacetamide / Q000494:pharmacology*; D000818:Animals; D002352:Carrier Proteins / Q000378:metabolism*; D002850:Chromatography, Gel; D003600:Cytosol / Q000378:metabolism*; D008099:Liver / Q000378:metabolism*; D008297:Male; D008970:Molecular Weight; D051381:Rats; D015032:Zinc / Q000378:metabolism; D015037:Zinc Radioisotopes
D000081:Acetamides; D002352:Carrier Proteins; D015037:Zinc Radioisotopes; C017800:zinc-binding protein; D000502:Allylisopropylacetamide; D015032:Zinc